Literature DB >> 12181752

Key role of mitochondria in cerulenin-mediated apoptosis.

S J Heiligtag1, R Bredehorst, K A David.   

Abstract

Cerulenin, a fungal metabolite, is known to be a specific inhibitor of fatty acid synthase. Here we report that cerulenin is an effective inducer of apoptosis in different wild-type p53 and mutant p53 tumor cell lines, whereas normal human keratinocytes and fibroblasts are resistant to the apoptotic effect. To get more insight into the mechanisms of how cerulenin induces apoptosis we investigated several signal transduction molecules, including p53, p73, p21/WAF1, Bax, cytochrome c, and caspases 3 and 9. Our data strongly indicate that mitochondria play a key role in the cerulenin-mediated pathway. Bax overexpression correlated with the extent of apoptosis and appears to be regulated in a p53-independent manner. The significance of the mitochondrial pathway for the cerulenin-mediated apoptosis was confirmed by the rapid mitochondrial release of cytochrome c both in wild-type p53 and mutant cell lines. Interestingly, the rapid release of cytochrome c was not accompanied by a breakdown of the mitochondrial potential. Instead, the complete disruption of the mitochondrial function coincided with the appearance of a p18 kDa cleavage product of Bax.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12181752     DOI: 10.1038/sj.cdd.4401055

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  15 in total

Review 1.  Polyunsaturated fatty acid metabolism in prostate cancer.

Authors:  Isabelle M Berquin; Iris J Edwards; Steven J Kridel; Yong Q Chen
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

Review 2.  Fatty acid synthase as a potential therapeutic target in cancer.

Authors:  Richard Flavin; Stephane Peluso; Paul L Nguyen; Massimo Loda
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

3.  Syringolin A, a new plant elicitor from the phytopathogenic bacterium Pseudomonas syringae pv. syringae, inhibits the proliferation of neuroblastoma and ovarian cancer cells and induces apoptosis.

Authors:  C S Coleman; J P Rocetes; D J Park; C J Wallick; B J Warn-Cramer; K Michel; R Dudler; A S Bachmann
Journal:  Cell Prolif       Date:  2006-12       Impact factor: 6.831

4.  Anti-Tumorigenic Potential of a Novel Orlistat-AICAR Combination in Prostate Cancer Cells.

Authors:  Clayton Wright; Anand Krishnan V Iyer; Vivek Kaushik; Neelam Azad
Journal:  J Cell Biochem       Date:  2017-05-23       Impact factor: 4.429

Review 5.  Targeting cancer cell mitochondria as a therapeutic approach.

Authors:  Shijun Wen; Daqian Zhu; Peng Huang
Journal:  Future Med Chem       Date:  2013-01       Impact factor: 3.808

6.  Increased fatty acid synthase as a potential therapeutic target in multiple myeloma.

Authors:  Wei-qin Wang; Xiao-ying Zhao; Hai-yan Wang; Yun Liang
Journal:  J Zhejiang Univ Sci B       Date:  2008-06       Impact factor: 3.066

7.  Mitochondrial function, apoptosis and cell cycle delay in the WEHI-3B leukaemia cell line and its variant Ciprofloxacin-resistant WEHI-3B/CPX.

Authors:  A Pessina; A Bonomi; S Casati; A Collotta; C Croera; E Marafante; F Palitti; L Gribaldo
Journal:  Cell Prolif       Date:  2007-08       Impact factor: 6.831

8.  Enhanced antiproliferative and apoptotic response of HT-29 adenocarcinoma cells to combination of photoactivated hypericin and farnesyltransferase inhibitor manumycin A.

Authors:  Veronika Sačková; Lucia Kuliková; Martin Kello; Ivana Uhrinová; Peter Fedoročko
Journal:  Int J Mol Sci       Date:  2011-11-29       Impact factor: 5.923

9.  Fatty acid synthase: a novel target for antiglioma therapy.

Authors:  W Zhao; S Kridel; A Thorburn; M Kooshki; J Little; S Hebbar; M Robbins
Journal:  Br J Cancer       Date:  2006-09-12       Impact factor: 7.640

10.  Fatty acid synthase is a novel therapeutic target in multiple myeloma.

Authors:  Yutaka Okawa; Teru Hideshima; Hiroshi Ikeda; Noopur Raje; Sonia Vallet; Tanyel Kiziltepe; Hiroshi Yasui; Sotaro Enatsu; Samantha Pozzi; Iris Breitkreutz; Diana Cirstea; Loredana Santo; Paul Richardson; Kenneth C Anderson
Journal:  Br J Haematol       Date:  2008-04-10       Impact factor: 8.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.